GLP-1
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
Whole Health Rx will be powered by WellSync, which develops customizable telehealth services for businesses.
The announcement comes less than a year after Virgin Pulse and HealthComp announced their $3 billion merger and their rebranding as Personify Health.
The new offerings and content will help members taking GLP-1 medications maximize nutrient intake and access medication tracking, recipes and community forums.
The offering will be available to plan sponsors and their employees within the Noom for Work employer program.